Sharekhan

BUY NOW Buy Shukra Pharmaceuticals Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock Shukra Pharmaceuticals Ltd

Tue 11/11/2025,16:1:0

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Shukra Pharmaceuticals Ltd

Your Vote -

Buy

58.33%

Hold

16.67%

Sell

25.00%

58.33%

12 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Shukra Pharmaceuticals Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Shukra Pharma - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 -

    10 Nov 2025, 3:04PM Incorporation of subsidiary company.

  • Shukra Pharma - Shareholder Meeting / Postal Ballot-Outcome of EGM

    1 Nov 2025, 3:55PM Proceeding of EOGM of the company.

  • Shukra Pharma - Board Meeting Intimation for Unaudited Financial Result For The Half Year Ended On 30TH September, 2025 Along

    31 Oct 2025, 7:00PM Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consid

  • Shukra Pharma - Receipt Of Distributorship Rights

    31 Oct 2025, 6:52PM Company has received distributionship rights.

  • Shukra Pharma - Intimation U/R 30 Of SEBI LODR- Incorporation Of Subsidiary Company

    24 Oct 2025, 7:35PM Incorporation of Subsidiary Company in India under the name \Shukra Helthtech Private Limited\

  • Shukra Pharma has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2025

    18 Oct 2025, 7:00PM As of September 2025, 50.95% is owned by Indian Promoters and 49.04% by Public. <p align=justify> Top five Promoters holding highest number of shares

  • Shukra Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    8 Oct 2025, 4:21PM As attached

  • Shukra Pharma - Authorization Received From Meril Healthcare Private Limited For The Project Of ROBOTIC ASSISTED SURGERY SYST

    8 Oct 2025, 2:23PM As attached.

  • Shukra Pharma - Notice Of Extra Ordinary General Meeting Of Shukra Pharmaceuticals Limited To Be Held On Saturday, November 0

    7 Oct 2025, 4:49PM EGM of the company scheduled to be held on November 01, 2025 at 11.30 am through VC.

  • Shukra Pharma - Board Meeting Outcome for Revised Outcome Of The Meeting Of The Board Of Directors Held On Friday, October 03

    4 Oct 2025, 12:56PM Revised outcome - pursuant to typographical error founded in the outcome submitted on october 03, 2025.

  • Shukra Pharma - Announcement under Regulation 30 (LODR)-Issue of Securities

    3 Oct 2025, 6:54PM Preferential Issue of 46,43,000 convertible equity warrants to promoter subject to approval from shareholders.

  • Shukra Pharma - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Held On Friday, October 03, 2025.

    3 Oct 2025, 6:51PM As attached.

  • Shukra Pharma - Voting Result Along With Scrutinizer Report Of 32Nd Annual General Meeting ('AGM') Of The Company Held On Sep

    3 Oct 2025, 3:05PM As attached.

  • Shukra Pharma - Shareholder Meeting / Postal Ballot-Outcome of AGM

    30 Sep 2025, 4:53PM Proceeding of the company.

  • Shukra Pharma - Board Meeting Intimation for Preferential Issue Of Warrants As Per Chapter V And In Accordance With Securitie

    22 Sep 2025, 4:29PM Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/10/2025 ,inter alia, to consid

  • Shukra Pharma has declared 1% Final dividend for the financial year March 2025

    13 Sep 2025, 9:30AM Shukra Pharmaceuticals Ltd. on Wednesday, 04 June 2025, has announced Final dividend of 1 percent on Equity Share, to its shareholders holding shares

  • Shukra Pharma - Intimation Of Book Closure And Record Date Pursuant To Regulation 42 Of SEBI Listing Regulations For Annual G

    12 Sep 2025, 5:52PM As attached.

  • Shukra Pharma - Intimation Of Record Date For Final Dividend For Financial Year 2024-2025.

    12 Sep 2025, 5:48PM Intimation of record date for the purpose of payment of final dividend for financial year 2024-2025.

  • Shukra Pharma - Corrigendum To The Notice Of 32ND Annual General Meeting And Annual Report (2024-25) Of The Company

    12 Sep 2025, 5:39PM As attached.

  • Shukra Pharma - Announcement Under Regulation 30 Of SEBI (LODR)- Strategic PAN India Distribution Tie-Up

    10 Sep 2025, 10:48AM THE SHUKRA PHARMACEUTICALS LIMITED HAS BEEN AUTHORISED BY WOCKHARDT LIMITED, ON A PAN INDIA BASIS TO REPRESENT, DISTRIBUTE AND MANAGE ITS PRODUCTS ACR

  • Shukra Pharma - Reg. 34 (1) Annual Report.

    8 Sep 2025, 7:31PM As attached

  • Shukra Pharma - Submission Of Notice Of 32Nd AGM Of The Companny.

    8 Sep 2025, 7:28PM As attached.

  • Shukra Pharmaceuticals bags Rs 24.06 cr Government-Backed Supply Contract for Afghanistan

    29 Aug 2025, 11:42AM Shukra Pharmaceuticals Ltd has announced that it has been awarded a contract by HSCC (India) Limited, a Government of India enterprise under the Minis

  • Shukra Pharma - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order

    28 Aug 2025, 7:11PM Company has received Letter of Award(LOA).

  • Shukra Pharma Q1 net profit zooms 110.20% at Rs 1.03 cr

    13 Aug 2025, 4:10PM The company reported standalone net profit of Rs 1.03 crore for the quarter ended June 30, 2025 as compared to Rs 0.49 crore in the same period last y

  • Shukra Pharma - Un-Audited Financial Results Of The Company For The First Quarter Ended June 30, 2025, Along With The Auditor

    13 Aug 2025, 3:49PM As Attached

  • Shukra Pharma - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Held On Wednesday, August 13, 2025

    13 Aug 2025, 3:44PM Un-Audited Financial Results of the Company for the First Quarter ended June 30, 2025, along with the Auditors' Limited Review Reports in accordance w
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Shukra Pharmaceuticals Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 67.0125 60.7935 30.3783 19.7265 25.3697
Liabilities 67.0125 60.7935 30.3783 19.7265 25.3697
Equity 43.7879 10.947 3.9142 1.5657 1.5656
Gross Profit 12.7296 19.4033 5.3633 2.8857 1.4438
Net Profit 9.5751 18.5372 4.4065 0.7507 0.0338
Cash From Operating Activities 7.9185 -5.1967 3.1695 7.7843 0.3715
NPM(%) 29.38 24.85 7.48 3.66 0.3
Revenue 32.5873 74.5729 58.8337 20.486 11.196
Expenses 19.8577 55.1696 53.4704 17.6003 9.7521
ROE(%) 17.63 34.14 8.11 1.38 0.06

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Shukra Pharmaceuticals Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 872.25 2.51 78.90 22.92 301.39 0.57
Lotus Eye Hospital and Institute Ltd 117.95 -0.04 379.32 83.52 3.55 0.00
Bharat Immunological and Biologicals Corporation Ltd 20.43 1.04 0.00 173.41 -39.50 0.00
Astec Lifesciences Ltd 618.25 0.02 0.00 78.76 -604.77 0.00

Company Info

1998 - Mrs. Riddhi M Patel, director of the company retires by rotation as per Provisions of the Act at this Annual General Meeting. 1999 - In accordance with the Companies Act, 1956 and Articles of Association of the Company, Mr. Mihir M Patel retire by rotation and is eligible for re-appointment. - Company has installed modern energy efficient machines. 2023 -Company issued rights shares of Rs. 10 in the ratio of 6:1 at a premium of Rs. 10 per share. 2024 -The Company has issued Bonus Shares in the Ratio of 3:1.

1998 - Mrs. Riddhi M Patel, director of the company retires by rotation as per Provisions of the Act at this Annual General Meeting. 1999 - In accordance with the Companies Act, 1956 and Articles of Association of the Company, Mr. Mihir M Patel retire by rotation and is eligible for re-appointment. - Company has installed modern energy efficient machines. 2023 -Company issued rights shares of Rs. 10 in the ratio of 6:1 at a premium of Rs. 10 per share. 2024 -The Company has issued Bonus Shares in the Ratio of 3:1.

Read More

Parent Organisation

Shukra Pharmaceuticals Ltd.

Founded

04/03/1993

Managing Director

Mr.Dakshesh Rameshchandra Shah

NSE Symbol

FAQ

The current price of Shukra Pharmaceuticals Ltd is

The 52-week high for Shukra Pharmaceuticals Ltd is

The market capitalization of Shukra Pharmaceuticals Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Shukra Pharmaceuticals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Shukra Pharmaceuticals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Shukra Pharmaceuticals Ltd shares.

The CEO of Shukra Pharmaceuticals Ltd is Mr.Dakshesh Rameshchandra Shah, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT